✦ LIBER ✦

Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia

✍ Scribed by Laura Z. Rassenti; Thomas J. Kipps

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 97 KB
Volume: 70B
Category: Article
ISSN: 1552-4949
DOI: 10.1002/cyto.b.20129

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical implications of ZAP-70 expressi

Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia

✍ Francesc Bosch; Ana Muntañola; Eva Giné; Ana Carrió; Neus Villamor; Carolina Mor 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Prognostic significance of combined anal

Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia

✍ Giovanni D'Arena; Michela Tarnani; Carlo Rumi; Tiziana Vaisitti; Semra Aydin; Ro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 1 views

Optimization of flow cytometric measurem

Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia

✍ Sergey N. Preobrazhensky; David W. Bahler 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

P163 Sequential and comparative Zap-70 a

P163 Sequential and comparative Zap-70 and CD38 analysis in chronic lymphoid leukemia patients

✍ Zs. Hevessy; E. Karaszi; A. Frendl; F. Kiss; G. Pfliegler; J. Kappelmayer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

lymphocytic leukemia. Besides establishing the demographic characteristics of 322 CLL cases studied, CD38 and ZAP7o was investigated in 58 vs. 64% of the cases while in 57% of the CLL cases FISH analysis for +12,13q ,11q and 17p was possible. Results: (1) The frequency of FISH detected aberrations i

The addition of rituximab to fludarabine

The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia

✍ Giovanni Del Poeta; Maria Ilaria Del Principe; Maria Antonietta Irno Consalvo; L 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Release and clinical significance of sol

Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia

✍ B.D. Hock; L.J. Fernyhough; S.M. Gough; A. Steinkasserer; A.G. Cox; J.L. McKenzi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 488 KB

Soluble CD83 (sCD83), a potent immunosuppressive agent, circulates at elevated levels in some chronic lymphocytic leukemia (CLL) patients. We report that CLL patients with elevated plasma sCD83 levels had significantly shorter (P=0.038) treatment free survival. Culture of CLL cells with solid phase